Advertisement
Advertisement


Commentary & Opinion

New York Times: HIV Treatment Should Be Started Earlier for Most, but Challenges Remain

March 19, 2013

Noting "French researchers have identified 14 adults" who appear to have been functionally cured of HIV after beginning treatment "within a couple of months of infection" and continuing treatment "for one to seven and a half years" before stopping, a New York Times editorial writes, "The researchers estimate that as many as 15 percent of adults who start treatment early and continue for at least a year may then be able to stop their drug regimen and live healthily without the drugs." The newspaper continues, "Although the study was small, the findings suggest that treatment should be started earlier for most people, a difficult feat without a lot more testing to identify who is infected and prompt treatment of those who test positive." The editorial writes, "The findings also suggest that many people taking antiviral drugs may be able to stop safely, provided doctors can find some sure way to identify them" (3/18).

Back to other news for March 2013


This information was reprinted from kff.org with permission from the Henry J. Kaiser Family Foundation. You can view the entire Kaiser Daily Global Health Policy Report, search the archives, and sign up for email delivery. © Henry J. Kaiser Family Foundation. All rights reserved.




This article was provided by Henry J. Kaiser Family Foundation. It is a part of the publication Kaiser Daily Global Health Policy Report. Visit the Kaiser Family Foundation's website to find out more about their activities, publications and services.
 

No comments have been made.
 

Add Your Comment:
(Please note: Your name and comment will be public, and may even show up in
Internet search results. Be careful when providing personal information! Before
adding your comment, please read TheBody.com's Comment Policy.)

Your Name:


Your Location:

(ex: San Francisco, CA)

Your Comment:

Characters remaining:

Advertisement

The content on this page is free of advertiser influence and was produced by our editorial team. See our content and advertising policies.